A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer. Byers LA, Navarro A, Schaefer E, Johnson M, et al. Clin Lung Cancer 2021 Apr 24. pii: S1525-7304(21)00089.

Read + Share

Amedeo Smart

Independent Medical Education

Byers LA, Navarro A, Schaefer E, Johnson M, et al. A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer. Clin Lung Cancer 2021 Apr 24. pii: S1525-7304(21)00089.
PMID: 34034991